Showing results (971-980 of 1,842) with videos related to

Sort By:
Pageof 185
ESMO Open|December 21, 2017
Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trialsEfrossini D Patsou, Georgios D Alexias, Fotios G Anagnostopoulos, et al.
ESMO Open|December 1, 2018
Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinomaGary Joseph Doherty, Deirdre Lynskey, Athena Matakidou, et al.
ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
ESMO Open|February 14, 2018
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapyChristian Manegold, Alex Adjei, Federico Bussolino, et al.
ESMO Open|March 6, 2018
Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trialHidehito Horinouchi, Kaoru Kubota, Akihiko Miyanaga, et al.
ESMO Open|January 21, 2023
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trialE de Azambuja, E Agostinetto, M Procter, et al.
ESMO Open|July 30, 2021
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)J A Perez-Fidalgo, A Cortés, E Guerra, et al.
ESMO Open|July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgeryP Pautier, A Floquet, C Chevreau, et al.
ESMO Open|October 30, 2020
Evaluation of the contribution of randomised cancer clinical trials evaluating agents without documented single-agent activityJared Foster, Boris Freidlin, E L Korn, et al.
ESMO Open|November 16, 2016
Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancerIsabel José Dionísio de Sousa, Joana Ferreira, Joana Rodrigues, et al.
Pageof 185